CG Oncology, Inc.

CGONNASDAQHealthcareBiotechnology

$61.56- (-)1Y +49.07%

As of Oct 26, 2026 close

Market cap: $5.43B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $35.80$80.97
Volume (live): -
Avg. volume (3M): 1.04M

CG Oncology, Inc. (CGON) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for CG Oncology, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy

Based on 12 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$92.30

+49.94% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest CGON Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 22, 2026	Unknown Analyst	Guggenheim	Initiates	Buy	$90.00
Sep 10, 2026	Gregory Renza	Truist	Maintains	Buy	-
Aug 20, 2026	David Dai	UBS	Reiterates	Buy	$90.00
Aug 17, 2026	Sean Laaman	Morgan Stanley	Reiterates	Buy	$93.00
Aug 13, 2026	Bret Jensen	TheStreet.com	Initiates Coverage	Hold	-
Aug 7, 2026	Sam Slutsky	LifeSci Capital	Maintains	Buy	$108.00
Aug 7, 2026	Joshua Schimmer	Cantor Fitzgerald	Reiterates	Buy	$105.00
Aug 7, 2026	Andres Y. Maldonado	HC Wainwright	Reiterates	Buy	$100.00
Aug 7, 2026	Kelsey Goodwin	Piper Sandler	Reiterates	Buy	$82.00 → $85.00 +3.00 (+3.7%)
Aug 7, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$87.00 → $88.00 +1.00 (+1.1%)
Aug 7, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$81.00 → $79.00 −2.00 (−2.5%)
Aug 6, 2026	Boris Peaker	JonesTrading	Maintains	Buy	$85.00
Aug 6, 2026	Joshua Schimmer	Cantor Fitzgerald	Reiterates	Buy	$105.00
Aug 6, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$81.00 → $79.00 −2.00 (−2.5%)

Unknown Analyst

Guggenheim

BuyInitiates

$90.00

Oct 22

Gregory Renza

Truist

BuyMaintains

Sep 10

David Dai

UBS

BuyReiterates

$90.00

Aug 20

Sean Laaman

Morgan Stanley

BuyReiterates

$93.00

Aug 17

Bret Jensen

TheStreet.com

HoldInitiates Coverage

Aug 13

Sam Slutsky

LifeSci Capital

BuyMaintains

$108.00

Aug 7

Joshua Schimmer

Cantor Fitzgerald

BuyReiterates

$105.00

Aug 7

Andres Y. Maldonado

HC Wainwright

BuyReiterates

$100.00

Aug 7

Kelsey Goodwin

Piper Sandler

BuyReiterates

$82.00 → $85.00

Aug 7

Alec Stranahan

BofA Securities

BuyReiterates

$87.00 → $88.00

Aug 7

Leonid Timashev

RBC Capital

BuyMaintains

$81.00 → $79.00

Aug 7

Boris Peaker

JonesTrading

BuyMaintains

$85.00

Aug 6

Joshua Schimmer

Cantor Fitzgerald

BuyReiterates

$105.00

Aug 6

Leonid Timashev

RBC Capital

BuyMaintains

$81.00 → $79.00

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CGON?

The analyst consensus rating for CGON is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for CGON?

The average 12-month price target for CGON is $92.30, representing an upside of 49.9% from the Oct 26, 2026 close of $61.56.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.